XML 87 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Debt And Financing Arrangements
6 Months Ended
Dec. 31, 2012
Debt And Financing Arrangements [Abstract]  
Debt And Financing Arrangements

 

Note 10.     Debt Financing Arrangements 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31

June 30

June 30

 

 

2012

2012

2011

 

 

(In millions)

 

 

 

 

 

 

 

 

0.875% Convertible Senior Notes $1.15 billion face amount, due in 2014

 

$

1,095 

$

1,071 

$

1,026 

 

 

 

 

 

 

 

 

4.479% Debentures $750 million face amount, due in 2021

 

 

754 

 

755 

 

756 

 

 

 

 

 

 

 

 

5.45% Notes $700 million face amount, due in 2018

 

 

700 

 

700 

 

700 

 

 

 

 

 

 

 

 

5.765% Debentures $596 billion face amount, due in 2041(1)

 

 

600 

 

1,007 

 

1,008 

 

 

 

 

 

 

 

 

5.375% Debentures $600 million face amount, due in 2035

 

 

588 

 

588 

 

587 

 

 

 

 

 

 

 

 

5.935% Debentures $420 million face amount, due in 2032(2)

 

 

416 

 

495 

 

495 

 

 

 

 

 

 

 

 

4.016% Debentures $570 million face amount, due in 2043

 

 

374 

 

 -

 

 -

 

 

 

 

 

 

 

 

4.535% Debentures $528 million face amount due in 2042

 

 

371 

 

370 

 

 -

 

 

 

 

 

 

 

 

8.375% Debentures $295 million face amount, due in 2017

 

 

293 

 

293 

 

292 

 

 

 

 

 

 

 

 

7.125% Debentures $243 million face amount, due in 2013

 

 

243 

 

243 

 

243 

 

 

 

 

 

 

 

 

7.5% Debentures $187 million face amount, due in 2027(3)

 

 

186 

 

221 

 

281 

 

 

 

 

 

 

 

 

7.0% Debentures $185 million face amount, due in 2031(4)

 

 

184 

 

193 

 

244 

 

 

 

 

 

 

 

 

6.625% Debentures $182 million face amount, due in 2029(5)

 

 

182 

 

196 

 

296 

 

 

 

 

 

 

 

 

6.95% Debentures $172 million face amount, due in 2097(6)

 

 

170 

 

173 

 

246 

 

 

 

 

 

 

 

 

6.45% Debentures $154 million face amount, due in 2038(7)

 

 

153 

 

157 

 

215 

 

 

 

 

 

 

 

 

6.75% Debentures $124 million face amount, due in 2027(8)

 

 

122 

 

139 

 

197 

 

 

 

 

 

 

 

 

Floating Rate Notes $1.4 billion face amount, due in 2012(9)

 

 

 -

 

1,399 

 

1,500 

 

 

 

 

 

 

 

 

8.125% Debentures $103 million face amount, due in 2012

 

 

 -

 

-

 

103 

 

 

 

 

 

 

 

 

Other

 

 

293 

 

212 

 

255 

Total long-term debt including current maturities

 

 

6,724 

 

8,212 

 

8,444 

Current maturities

 

 

(268)

 

(1,677)

 

(178)

Total long-term debt

 

$

6,456 

$

6,535 

$

8,266 

 

 

 

 

 

 

 

 

(1)$1.0 billion face amount as of June 30, 2012

 

 

 

 

 

 

 

(2) $500 million face amount as of June 30, 2012

 

 

 

 

 

 

 

(3) $222 million and $282 million face amount as of June 30, 2012 and 2011, respectively

(4) $194 million and $246 million face amount as of June 30, 2012 and 2011, respectively

(5) $197 million and $298 million face amount as of June 30, 2012 and 2011, respectively

(6) $176 million and $250 million face amount as of June 30, 2012 and 2011, respectively

(7) $158 million and $215 million face amount as of June 30, 2012 and 2011, respectively

(8) $141 million and $200 million face amount as of June 30, 2012 and 2011, respectively

(9) $1.5 billion face amount as of June 30, 2011

 

 

In October 2012, the Company issued $570 million of 4.016% debentures due in 2043 (the 2012 Debentures) in exchange for $568 million of its previously issued and outstanding 5.765%, 5.935%, 6.45%, 6.625%, 6.75%, 6.95%, 7% and 7.5% debentures.  The Company paid $196 million of debt premium to certain bondholders associated with these exchanges.  The discount on the 2012 Debentures and debt premium paid to the bondholders is being amortized over the life of the 2012 Debentures using the effective interest method. 

 

On September 26, 2011, the Company issued $528 million of 4.535% senior debentures due in 2042 (the 2011 Debentures) in exchange for $404 million of its previously issued and outstanding 6.45%, 6.625%, 6.75%, 6.95%, 7% and 7.5% debentures.  The Company paid $32 million of debt premium to certain bondholders associated with these exchanges.  The discount on the 2011 Debentures is being amortized over the life of the 2011 Debentures using the effective interest method. 

 

In June 2008, the Company issued $1.75 billion of Equity Units, which were a combination of debt and a forward contract for the holder to purchase the Company’s common stock.  The debt and equity instruments were deemed to be separate instruments as the investor may transfer or settle the equity instrument separately from the debt instrument.  On March 30, 2011, the Company initiated a remarketing of the $1.75 billion 4.7% debentures underlying the Equity Units into two tranches:  $0.75 billion principal amount of 4.479% notes due in 2021 and $1.0 billion principal amount of 5.765% debentures due in 2041.  As a result of the remarketing, the Company was required to use the “if-converted” method of calculating diluted earnings per share with respect to the forward contracts for the quarter ended March 31, 2011 (see Note 11).  The Company incurred early extinguishment of debt charges of $8 million as a result of the debt remarketing.  The forward purchase contracts underlying the Equity Units were settled on June 1, 2011, for 44 million shares of the Company’s common stock in exchange for receipt of $1.75 billion in cash. 

 

On February 11, 2011, the Company issued $1.5 billion in aggregate principal amount of floating rate notes due on August 13, 2012.  Interest on the notes accrued at a floating rate of three-month LIBOR reset quarterly plus 0.16% and was paid quarterly.    In August 2012, the Company paid the remaining outstanding balance of these notes with funds available from short-term borrowings. 

 

In February 2007, the Company issued $1.15 billion principal amount of convertible senior notes due in 2014 (the Notes) in a private placement.  The Notes were issued at par and bear interest at a rate of 0.875% per year, payable semiannually.  The Notes are convertible based on an initial conversion rate of 22.8423 shares per $1,000 principal amount of Notes (which is equal to a conversion price of approximately $43.78 per share).  The Notes may be converted, subject to adjustment, only under the following circumstances: 1) during any calendar quarter beginning after March 31, 2007, if the closing price of the Company’s common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the immediately preceding quarter is more than 140% of the applicable conversion price per share, which is $1,000 divided by the then applicable conversion rate, 2) during the five consecutive business day period immediately after any five consecutive trading day period (the note measurement period) in which the average of the trading price per $1,000 principal amount of Notes was equal to or less than 98% of the average of the product of the closing price of the Company’s common stock and the conversion rate at each date during the note measurement period, 3) if the Company makes specified distributions to its common stockholders or specified corporate transactions occur, or 4) at any time on or after January 15, 2014, through the business day preceding the maturity date.  Upon conversion, a holder would receive an amount in cash equal to the lesser of 1) $1,000 and 2) the conversion value, as defined.  If the conversion value exceeds $1,000, the Company will deliver, at the Company’s election, cash or common stock or a combination of cash and common stock for the conversion value in excess of $1,000.  If the Notes are converted in connection with a change in control, as defined, the Company may be required to provide a make-whole premium in the form of an increase in the conversion rate, subject to a stated maximum amount.  In addition, in the event of a change in control, the holders may require the Company to purchase all or a portion of their Notes at a purchase price equal to 100% of the principal amount of the Notes, plus accrued and unpaid interest, if any.  In accordance with applicable accounting standards, the Company recognized the Notes proceeds received in 2007 as long-term debt of $853 million and equity of $297 million.  The discount on the long-term debt is being amortized over the life of the Notes using the effective interest method. Discount amortization expense of $24 million, $22 million, $45 million, $43 million, and $40 million for the six months ended December 31, 2012 and 2011 and the years ended June 30, 2012, 2011, and 2010, respectively, were included in interest expense related to the Notes. 

 

Concurrent with the issuance of the Notes, the Company purchased call options in private transactions at a cost of $300 million.  The purchased call options allow the Company to receive shares of its common stock and/or cash from the counterparties equal to the amounts of common stock and/or cash related to the excess of the current market price of the Company’s common stock over the exercise price of the purchased call options.  In addition, the Company sold warrants in private transactions to acquire, subject to customary anti-dilution adjustments, 26.3 million shares of its common stock at an exercise price of $62.56 per share and received proceeds of $170 million.  If the average price of the Company’s common stock during a defined period ending on or about the respective settlement dates exceeds the exercise price of the warrants, the warrants will be settled, at the Company’s option, in cash or shares of common stock.  The purchased call options and warrants are intended to reduce the potential dilution upon future conversions of the Notes by effectively increasing the initial conversion price to $62.56 per share.  The net cost of the purchased call options and warrant transactions of $130 million was recorded as a reduction of shareholders’ equity.  The purchased call options expire on the maturity date of the Notes and the warrants expire shortly thereafter.   

 

As of December 31, 2012, none of the conditions permitting conversion of the Notes had been satisfied.  In addition, as of December 31, 2012, the market price of the Company’s common stock was not greater than the exercise price of the purchased call options or warrants.  As of December 31, 2012, no share amounts related to the conversion of the Notes or exercise of the warrants are included in diluted average shares outstanding. 

 

At December 31, 2012, the fair value of the Company’s long-term debt exceeded the carrying value by $1.4 billion, as estimated using quoted market prices (a Level 2 measurement under applicable accounting standards). 

 

The aggregate maturities of long-term debt for the five years after December 31, 2012, are $268  million, $1.1 billion, $19 million, $13 million, and $303 million, respectively. 

  

At December 31, 2012, the Company had lines of credit totaling $8.5 billion, of which $5.7 billion were unused.  The weighted average interest rates on short-term borrowings outstanding at December 31, 2012 and June 30, 2012 and 2011, were 0.70%, 0.78%, and 0.65%, respectively.  Of the Company’s total lines of credit, $6.0 billion support a commercial paper borrowing facility, against which there was $2.0 billion of commercial paper outstanding at December 31, 2012.

 

The Company’s credit facilities and certain debentures require the Company to comply with specified financial and non-financial covenants including maintenance of minimum tangible net worth as well as limitations related to incurring liens, secured debt, and certain other financing arrangements.  The Company is in compliance with these covenants as of December 31, 2012.  

 

The Company has outstanding standby letters of credit and surety bonds at December 31, 2012 and June 30, 2012 and 2011, totaling $911 million, $644 million and $729 million, respectively. 

 

On March 27, 2012, the Company entered into an amendment of its accounts receivable securitization program (the “Program).  The Program provides the Company with up to $1.0 billion in funding resulting from the sale of accounts receivable.  As of December 31, 2012, the Company utilized all of its $1.0 billion facility under the Program (see Note 20 for more information on the Program).